+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Japan COVID-19 diagnostics Market 2020-2026

  • ID: 5190212
  • Report
  • October 2020
  • Region: Japan
  • Orion Market Research Private Limited

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Eiken Chemical Co., Ltd.
  • Fujirebio Inc.
  • Shionogi & Co., Ltd.
  • Sysmex Corp.
  • TOSOH Corp.
  • Toyobo Co., Ltd.
  • MORE
Japan COVID-19 diagnostics Market Size, Share & Trends Analysis Report by Type (Instruments, Reagents & Kits, and Laboratory Testing Services), by Technology Type (PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test), by Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Blood, Urine, Saliva, and Others), and by End-Users (Laboratories, Hospitals, Diagnostic Centers & Clinics, and Research Institutes) and Forecast, 2020-2026
Japan COVID-19 diagnostics market is estimated to see a decline in CAGR of 14.7% during the forecast period. Japan has a significant share in the global COVID-19 diagnostics market owing to the growing diagnostic tests in the country coupled with the introduction of new diagnostic test for COVID-19 in the country. For instance, on 13th May 2020, the first antigen test to detect SARS-CoV-2 was approved in Japan by the Ministry of Health, Labor and Welfare (MHLW) in Japan. This product reached marketing approval within three weeks from its regulatory submission and approved through the regular review scheme. Through this new diagnostic test, quick virus detection will be enabled, and testing capacity for COVID-19 in Japan will be strengthened and expanded.

Japan COVID-19 diagnostics market is segmented on the basis of technology type, end-use, sample type, and product type. By end-use, the COVID-19 diagnostic market is divided into laboratories, hospitals, diagnostic centers & clinics, and research institutes. By product type, the market is further segmented into instruments, reagents & kits, and laboratory testing services. By Sample type, the market is divided into oropharyngeal & nasopharyngeal swabs, blood, urine, saliva, and others. By technology type, the market is further segmented into PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test. Among these, the PCR segment has a major share in the COVID-19 diagnostics market. The factor that enhances the PCR test adoption includes a wide availability of tests and generation of the accurate results. However, due to its time consuming and expensive nature, these tests are substituted with other tests such as serology tests.

The companies which are contributing to the growth of the Japan COVID-19 diagnostics market include Otsuka Pharmaceutical Co., Ltd., Sysmex Corp., TOSOH Corp., Fujirebio Inc., and Eiken Chemical Co., Ltd. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market.

Research Methodology

The market study of the Japan COVID-19 diagnostics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors.

Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.
The report provides an in-depth analysis of market size, various services offered by the players, and market opportunity. The report will serve as a source for 360-degree analysis of the market delivering insights for making better business decisions.

Market Segmentation

1. Japan COVID-19 Diagnostics Market Research and Analysis by Type
2. Japan COVID-19 Diagnostics Market Research and Analysis by Technology Type
3. Japan COVID-19 Diagnostics Market Research and Analysis by Sample Type
4. Japan COVID-19 Diagnostics Market Research and Analysis by End-User

The Report Covers
  • Comprehensive research methodology of the Japan COVID-19 diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Japan COVID-19 diagnostics market.
  • Insights about market determinants which are stimulating the Japan COVID-19 diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Eiken Chemical Co., Ltd.
  • Fujirebio Inc.
  • Shionogi & Co., Ltd.
  • Sysmex Corp.
  • TOSOH Corp.
  • Toyobo Co., Ltd.
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Market Determinants
3.1. Motivators
3.2. Restraints
3.3. Opportunities

4. Market Segmentation
4.1. Japan COVID-19 Diagnostics Market by Type
4.1.1. Instruments
4.1.2. Reagents & Kits
4.1.3. Laboratory Testing Services
4.2. Japan COVID-19 Diagnostics Market by Technology Type
4.2.1. PCR Test
4.2.2. Antigen Test
4.2.2.1. Chromatographic Immunoassay
4.2.2.2. Fluorescent Immunoassay
4.2.2.3. Chemiluminescent Immunoassay
4.2.3. Serology Test
4.2.3.1. Enzyme-Linked Immunosorbent Assay (ELISA)
4.2.3.2. Neutralization
4.2.3.3. Chemiluminescent Immunoassay
4.2.4. Rapid/ PoC Test
4.3. Japan COVID-19 Diagnostics Market by Sample Type
4.3.1. Oropharyngeal & Nasopharyngeal Swabs
4.3.2. Blood
4.3.3. Urine
4.3.4. Saliva
4.3.5. Others (Sperm)
4.4. Japan COVID-19 Diagnostics Market by End-Users
4.4.1. Laboratories
4.4.2. Hospitals
4.4.3. Diagnostic Centers & Clinics
4.4.4. Research Institutes

5. Company Profiles
5.1. Eiken Chemical Co., Ltd.
5.2. Fujirebio Inc.
5.3. Otsuka Pharmaceutical Co., Ltd.
5.4. Shionogi & Co., Ltd.
5.5. Sysmex Corp.
5.6. TOSOH Corp.
5.7. Toyobo Co., Ltd.

List of Tables

List of Figures
Note: Product cover images may vary from those shown
  • Eiken Chemical Co., Ltd.
  • Fujirebio Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Shionogi & Co., Ltd.
  • Sysmex Corp.
  • TOSOH Corp.
  • Toyobo Co., Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll